NSABP B-51/RTOG 1304 presented at #NRG2024

💥cN1 breast cancer pts who converted to ypN0 with neoadj chemo
💥no SS DFS or OS benefit to WBRT + RNI or CW RT inc RNI (superiority design)
💥thread below includes details from presentation

1/7

NRG Oncology

Local steroid injection in severe idiopathic granulomatous mastitis patients can be effective as solo therapy in some patients and control symptoms in others in conjunction with systemic steroids.

#ASBrS23 #bcsm #quickshots

How should we apply the Choosing Wisely guideline for omission of SLNB to women >70 with invasive lobular carcinoma?

🔹Study of NCDB data comparing patients over 70 with ILC & IDC

🔸No diff in pathologic positive slnb rates

#ASBrS23 #bcsm #quickshots

Manuscript will be online in JCO on Tuesday March 28th.

#MarginStatus and Local Recurrence in #Phyllodes Tumours of the Breast: A Canadian Series rdcu.be/c7Qqs Ipshita Prakash McGill Surgery #VisualAbstract Kelly McMasters, MD, PhD

To clip or not clip. To TAD or not TAD. Important topic and great review by Sergio Israel Aguilar! ASBrS Society of Surgical Oncology AnnalsSurgOncology Memorial Sloan Kettering Cancer Center

Great invited lecture about fertility and pregnancy in #breastcancer #ABSCONF22 . Important to have MDT approach, but reassuring outcomes similar.

Very neglected area in our health systems globally - appropriate and resourced palliative care services

Peter Raubenheimer Graeme Meintjes Agreed. It should be a basic competency, taught at undergraduate level, infused in every rotation, for every discipline. At the moment we have one week for medical students 3/4th year, and oncology registrars. Nothing for nurses or social workers or acute care/renal/neuro etc etc

ER+PR- and ER-PR+ invasive breast cancer subtypes are more likely to have unfavorable characteristics and worse survival than ER+PR+ cancers, suggesting that a paradigm shift is needed in 'hormone receptor positive' breast cancer rdcu.be/b5UQz AnnalsSurgOncology ASBrS

The new oxygen tank that was put in at Groote Schuur Hospital at the beginning of the pandemic. You can’t treat COVID without oxygen. Every hospital manager in the country should have been sorting this out over the last few months. If not they should get a new job

In BJS' June issue: Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction ow.ly/xttF30qRa8o Amy Lee Lightner, MD Bas Wijnhoven Des Winter Kjetil Søreide Malin Sund Martyn Evans Robert Hinchliffe

Maverick Citizen Op-Ed: A fundamental shift is required to pool health resources to ensure public sector patients aren’t left behind dailymaverick.co.za/article/2020-0…

Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials - ScienceDirect Time to change. sciencedirect.com/science/articl…

65% reduction in patient time on treatment . Roll it out 👋

Neoadjuvant #chemotherapy makes breast conservation possible in half of patients with stages II to III TNBC who would have otherwise required #mastectomy ja.ma/2usYD5P Mehra Golshan MD MBA FACS

news.google.com/articles/CBMie…

With ERAS®, same-day discharge is a safe and feasible option for #mastectomy patients. #BreastCancer . #VisualAbstract by Kristen Jogerst. Kelly McMasters, MD, PhD Society of Surgical Oncology ow.ly/eera50zgsoG